Literature DB >> 8649793

Altered AP-1/ATF complexes in adenovirus-E1-transformed cells due to EIA-dependent induction of ATF3.

B M Hagmeyer1, M C Duyndam, P Angel, R P de Groot, M Verlaan, P Elfferich, A van der Eb, A Zantema.   

Abstract

The adenovirus (Ad) E1A proteins alter the expression level and activity of AP-1/ATF transcription factors. Previously we have shown that in AdE1-transformed cells cJun is hyperphosphorylated in its N-terminal transactivation domain, which parallels enhanced transactivation function. To find out whether the interaction between cJun and other cellular proteins is altered, we have searched for proteins which would physically associate with cJun. In this report we show that in AdE1-transformed cells cJun specifically associates with two proteins of 21 and 23 kD. These proteins are not expressed at detectable levels in the parental cells or in cells transformed by oncogenes other than AdE1. The cJun-associated proteins represent different forms of the bZIP transcription factor ATF3, the human homolog of rat LRF1. The expression of ATF3 is induced in AdE1-transformed cells and is a direct effect of the expression of E1A. Through induction of ATF3 expression and the subsequent formation of cJun/ATF3 heterodimers, E1A alters the repertoire of AP-1/ATF factors and may thereby redirect the corresponding gene-expression program. Since the induction of ATF3 is a function of sequences within the transforming 12S-ElA protein, cJun/ATF3 complexes might be involved in establishing cellular transformation by AdE1A.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8649793

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

Review 1.  ATF3 and stress responses.

Authors:  T Hai; C D Wolfgang; D K Marsee; A E Allen; U Sivaprasad
Journal:  Gene Expr       Date:  1999

2.  Scaffold/matrix attachment region elements interact with a p300-scaffold attachment factor A complex and are bound by acetylated nucleosomes.

Authors:  Joost H A Martens; Matty Verlaan; Eric Kalkhoven; Josephine C Dorsman; Alt Zantema
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

3.  E1A + cHa-ras transformed rat embryo fibroblast cells are characterized by high and constitutive DNA binding activities of AP-1 dimers with significantly altered composition.

Authors:  T V Pospelova; A V Medvedev; A N Kukushkin; S B Svetlikova; A J van der Eb; J C Dorsman; V A Pospelov
Journal:  Gene Expr       Date:  1999

4.  An alternatively spliced isoform of transcriptional repressor ATF3 and its induction by stress stimuli.

Authors:  Yoshinori Hashimoto; Chun Zhang; Junya Kawauchi; Issei Imoto; Mimi T Adachi; Johji Inazawa; Teruo Amagasa; Tsonwin Hai; Shigetaka Kitajima
Journal:  Nucleic Acids Res       Date:  2002-06-01       Impact factor: 16.971

5.  p300 and ATF-2 are components of the DRF complex, which regulates retinoic acid- and E1A-mediated transcription of the c-jun gene in F9 cells.

Authors:  H Kawasaki; J Song; R Eckner; H Ugai; R Chiu; K Taira; Y Shi; N Jones; K K Yokoyama
Journal:  Genes Dev       Date:  1998-01-15       Impact factor: 11.361

6.  Differential targeting of the stress mitogen-activated protein kinases to the c-Jun dimerization protein 2.

Authors:  Sigal Katz; Ami Aronheim
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

7.  The transcription factor ATF3 is upregulated during chondrocyte differentiation and represses cyclin D1 and A gene transcription.

Authors:  Claudine G James; Anita Woods; T Michael Underhill; Frank Beier
Journal:  BMC Mol Biol       Date:  2006-09-19       Impact factor: 2.946

8.  Integrative modeling reveals the principles of multi-scale chromatin boundary formation in human nuclear organization.

Authors:  Benjamin L Moore; Stuart Aitken; Colin A Semple
Journal:  Genome Biol       Date:  2015-05-27       Impact factor: 13.583

9.  Inhibitory effect of ATF3 antisense oligonucleotide on ectopic growth of HT29 human colon cancer cells.

Authors:  T Ishiguro; H Nagawa; M Naito; T Tsuruo
Journal:  Jpn J Cancer Res       Date:  2000-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.